5th Annual Meeting of the Society for Translational Oncology (STO)

For the fifth year, this symposium of notable speakers, representing both research and clinical practice, will convene before a fully engaged audience, providing a unique opportunity for education, interaction and collaboration.

Cancer treatment has progressed within the last decade. Researchers have a better understanding of cancer biology and viral oncology; clinical studies have identified potential cancer biomarkers, and researchers are investigating how genetic variations could be used to stratify patients for risk as well as treatment. The development of targeted therapies is advancing the practice of individualized medicine.

Ongoing professional education is an essential component of improving patient care and outcomes in the oncology setting, where advances occur rapidly. Professional education activities help clinicians to identify best practice models, develop new clinical skills, and put current knowledge into action.